Skip to content
★ Sign in to follow
PB

Philip Broadley

Board Director
Director
Total declarations
3
Company
1
▲ Purchases (1 ops.)
€120k
▼ Sales (0 ops.)
—

Latest filing published 18 Dec 2025 for AstraZeneca PLC.

Filing timeline

BuySale
Philip Broadley

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Philip Broadley: trading record in brief

All filings by Philip Broadley on record concern AstraZeneca PLC, in the capacity of board member. Over a trading history stretching from 13 November 2024 to 17 December 2025, the count stands at 3 filings.

Every open-market trade on record is a purchase: 1 purchase worth €120k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

The record was last updated on 18 December 2025 with a transaction in AstraZeneca PLC. The last insider purchase was made public on 13 November 2024, 726 days ago. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. The regulation allows three business days to notify a trade (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Philip Broadley

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ●
    StyrelseledamotExecutivesAstraZeneca PLC
    0FI-SE
    5,735 shares0AktieISIN GB0009895292FI:A003U857-1
  • ●
    StyrelseledamotExecutivesAstraZeneca PLC
    0FI-SE
    5,735 shares0AktieISIN GB0009895292FI:A003U856-1
  • ▲
    StyrelseledamotExecutivesAstraZeneca PLC
    99,665 GBP10FI-SE
    980 shares@ £101.699130.1% of flowAktieISIN GB0009895292FI:csv-835fc0e963dca97537ea
    Canonical exit: 11 Feb 2025 (T+90)

3 of 3 declarations